Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intercept Pharma (ICPT)
NASDAQ:ICPT
Holding ICPT?
Track your performance easily
ICPT Stock Chart & Stats
Day’s Range$18.98 - $19.01
52-Week Range― - ―
Previous Close$18.96
Volume3.96M
Average Volume (3M)N/A
Market Cap
$794.69M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$19.00Price Target Upside0.00%
Rating ConsensusHold
Number of Analyst Covering9
Intercept Pharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ICPT FAQ
What was Intercept Pharma’s price range in the past 12 months?
Currently, no data Available
What is Intercept Pharma’s market cap?
Currently, no data Available
When is Intercept Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Intercept Pharma’s earnings last quarter?
Currently, no data Available
Is Intercept Pharma overvalued?
According to Wall Street analysts Intercept Pharma’s price is currently same.
Does Intercept Pharma pay dividends?
Intercept Pharma does not currently pay dividends.
What is Intercept Pharma’s EPS estimate?
Intercept Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intercept Pharma have?
Currently, no data Available
What happened to Intercept Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Intercept Pharma?
Among the largest hedge funds holding Intercept Pharma’s share is Deerfield Management Company, LP. It holds Intercept Pharma’s shares valued at 23M.
---
Intercept Pharma Stock Smart Score
Company Description
Intercept Pharma
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.
---
ICPT Stock 12 Month Forecast
Average Price Target
$19.00
▲(0.00% Upside)
Technical Analysis
Best Analysts Covering ICPT
1 Year
1 Year Success Rate
10/27 ratings generated profit
1 Year Average Return
-2.99%
assigned a buy rating a year ago
Copying Brian Skorney's trades and holding each position for 1 Year would result in 37.04% of your transactions generating a profit, with an average return of -2.99% per trade.
---